A qualitative descriptive analysis of effects of psychedelic phenethylamines and tryptamine
Palamar, J. J., & Acosta, P. | Clinical and Experimental | 07 January 2020
Esketamine is approved in Europe for treating resistant major depressive disorder
Mahase, E. | BMJ | 20 December 2019
Neurochemical and Behavioral Profiling in Male and Female Rats of the Psychedelic Agent 25I-NBOMe
Miliano, C., Marti, M., Pintori, N., Castelli, M. P., Tirri, M., Arfè, R., & De Luca, M. A. | Frontiers in Pharmacology | 12 December 2019
Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment
Uthaug, M. V., Lancelotta, R., Szabo, A., Davis, A. K., Riba, J., & Ramaekers, J. G. | Psychopharmacology | 10 December 2019
Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders
Sartori, S. B., & Singewald, N. | Pharmacology & therapeutics | 27 August 2019
Effects of the synthetic psychedelic 2,5-dimethoxy-4-iodoamphetamine (DOI) on ethanol consumption and place conditioning in male mice.
Oppong-Damoah, A., Curry, K. E., Blough, B. E., Rice, K. C., & Murnane, K. S. | Psychopharmacology | 15 July 2019
REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics.
Carhart-Harris, R. L., & Friston, K. J. | Pharmacological reviews | 1 July 2019
REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics
Carhart-Harris, R. L., & Friston, K. J. | Pharmacological reviews | 20 June 2019
Return of the lysergamides. Part V: Analytical and behavioural characterization of 1-butanoyl-d-lysergic acid diethylamide (1B-LSD).
Brandt, S. D., Kavanagh, P. V., Westphal, F., Stratford, A., Elliott, S. P., Dowling, G., ... & Halberstadt, A. L. | Drug testing and analysis | 18 June 2018
Motives and side-effects of microdosing with psychedelics among users
Hutten, N. R., Mason, N. L., Dolder, P. C., & Kuypers, K. P. | International Journal of Neuropsychopharmacology | 31 May 2019
Palliative Nursing and Sacred Medicine: A Holistic Stance on Entheogens, Healing, and Spiritual Care.
Rosa, W. E., Hope, S., & Matzo, M. | Journal of Holistic Nursing | 18 April 2018
A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms
Uthaug, M. V., Lancelotta, R., van Oorsouw, K., Kuypers, K. P. C., Mason, N., Rak, J., ... & Páleníček, T. | Psychopharmacology | 13 April 2019
Effects of the Psychedelic Amphetamine MDA (3,4-Methylenedioxyamphetamine) in Healthy Volunteers.
Baggott, M. J., Garrison, K. J., Coyle, J. R., Galloway, G. P., Barnes, A. J., Huestis, M. A., & Mendelson, J. E. | Journal of psychoactive drugs | 9 April 2019
Classic psychedelics: the special role of the visual system
Császár-Nagy, N., Kapócs, G., & Bókkon, I. | Reviews in the neurosciences | 2 April 2019
5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety
Davis, A. K., So, S., Lancelotta, R., Barsuglia, J. P., & Griffiths, R. R.| The American journal of drug and alcohol abuse | 1 March 2019
Recreational use of psychedelics is associated with elevated personality trait openness: Exploration of associations with brain serotonin markers
Erritzoe, D., Smith, J., Fisher, P. M., Carhart-Harris, R., Frokjaer, V. G., & Knudsen, G. M.| Journal of Psychopharmacology | 28 February 2019
Long-lasting analgesic effect of the psychedelic drug changa: A case report
Ona, G., & Troncoso, S. | Journal of Psychedelic Studies |12 February 2019
The tripping point: The potential role of psychedelic-assisted therapy in the response to the opioid crisis
Argento, E., Tupper, K. W., & Socias, M. E. | International Journal of Drug Policy | 7 February 2019
A systematic study of microdosing psychedelics
Polito, V., & Stevenson, R. J. | PloS one | 6 February 2019
How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review.
Hoch, E., Niemann, D., von Keller, R., Schneider, M., Friemel, C. M., Preuss, U. W., ... & Pogarell, O. | European archives of psychiatry and clinical neuroscience | 31 January 2019
Neurochemical models of near-death experiences: A large-scalestudy based on the semantic similarity of written reports
Martial, C., Cassol, H., Charland-Verville, V., Pallavicini, C., Sanz, C., Zamberlan, F., & Tagliazucchi, E. | Consciousness and cognition | 20 January 2019
Transformative Psychopharmacology: the Case of 5-Methoxy-N,N-Dimethyltryptamine
Jan M Keppel Hesselink | International Journal of Psychotherapy Practice and Research | 2 January 2019
How do psychedelics work?
Carhart-Harris, R. L. | Current opinion in psychiatry | 1 January 2019
DARK Classics in Chemical Neuroscience: Atropine, Scopolamine, and Other Anticholinergic Deliriant Hallucinogens
Lakstygal, A., Kolesnikova, T., Khatsko, S., Zabegalov, K., Volgin, A., Demin, K., & Kalueff, A. | ACS chemical neuroscience | 19 December 2018
A Jamesian Response to Reductionism in the Neuropsychology of Religious Experience
Kime, K. G., & Snarey, J. R. | Archive for the Psychology of Religion | 13 December 2018